key: cord-0977064-7i4fnlsc
authors: Al‐Dawsari, Najla A.; Abulhamayel, Yem
title: COVID‐19 elbows: first report in Saudi Arabia
date: 2020-09-29
journal: Int J Dermatol
DOI: 10.1111/ijd.15182
sha: 4022c5c3cf18e33cd99ad228a2672ff63c108fcf
doc_id: 977064
cord_uid: 7i4fnlsc

nan

A 39-year-old otherwise healthy female radiologist tested positive for SARS-CoV-2 via polymerase chain reaction 6 days after coming in direct contact with her SARS-CoV-2-positive husband. Her husband contracted the infection at his workplace. She presented with fever, sore throat, headaches, and body aches. After spending two days in home quarantine after being tested, she suddenly developed an intensely pruritic rash over both elbows (Fig. 1) . She had no history of local pressure exerted on the affected sites, and she denied using any topical agents that could have caused contact dermatitis before the onset of the rash. She had no history of similar rashes previously and no personal or family history of psoriasis. She was not on any medications, except paracetamol for fever and body aches. A past history of paracetamol allergy was absent. After 4 days of topical application of mometasone furoate 0.1% ointment, the rash improved. A few days later, she developed a similar rash on her knees. However, the rash was faint and mild and resolved without residual skin changes. The differential diagnosis included urticaria, urticarial vasculitis, psoriasis, or a viral rash related to SARS-CoV-2. A biopsy could not be per- for about four days, hence, a viral rash was suspected. The absence of residual skin changes excluded urticarial vasculitis. As the rash did not recur after discontinuing the topical steroid, a diagnosis of psoriasis was excluded. A skin biopsy could have aided our diagnosis. On three weeks follow-up, the rash did not recur. We believe that this report could be a helpful addition to the ongoing studies on the cutaneous manifestations of SARS-CoV-2. 4 

Cutaneous Manifestations in COVID-19: a new contribution

Classification of the cutaneous manifestations of COVID19a rapid prospective nationwide consensus study in Spain with 375 cases

Skin manifestations of COVID-19

The patient in this manuscript provided written informed consent for publication of their case details. There were no funding sources.